Researchers at the University of Louisville have joined the coronavirus treatment and prevention fray, announcing Wednesday they believe a technology they developed could block the virus from infecting human cells.
It's based on a piece of synthetic DNA (also known as an aptamer) which targets and binds with a human protein called nucleolin. Early research and experiments, led by researchers Paula Bates, John Trent, and Don Miller, indicate the aptamer may be effective at preventing the coronavirus from "hijacking" nucleolin to replicate inside the body at doses previously shown to be safe in patients. The Louisville team has applied the same aptamer in a variety of ways, and it has reportedly emerged as a potential therapeutic drug for multiple types of cancer.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
A Man on the Inside: Netflix comedy leaves you with a 'warm fuzzy feeling'The Week Recommends Charming series has a 'tenderness' that will 'sneak up' on you
-
Bread & Roses: an 'extraordinarily courageous' documentaryThe Week Recommends Sahra Mani's 'powerful' film examines the lives of three Afghan women under the Taliban
-
V13: a 'marvelous and terrifying' account of the Bataclan terror trialsThe Week Recommends Emmanuel Carrère's work is 'absolutely gripping'
-
ACA opens 2025 enrollment, enters 2024 raceSpeed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
-
McDonald's sued over E. coli linked to burgerSpeed Read The outbreak has sickened at least 49 people in 10 states and left one dead
-
Long Covid: study shows damage to brain's 'control centre'The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
-
FDA OKs new Covid vaccine, available soonSpeed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
-
Mpox: how dangerous is new health emergency?Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
-
What is POTS and why is it more common now?The explainer The condition affecting young women
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry reportThe Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
-
Should masks be here to stay?Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
